111In-DPI-4501

N/A

Report date: 2025/11/20 16:04:34

NME

Base Information

Drug Name111In-DPI-4501

Drug Alias Name111In-DPI-4501DPI-4501

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionRadionuclide imaging enhancersCarbonic anhydrase IX binders

TargetsCarbonic anhydrase IX

Therapy Area/IndicationsColorectal NeoplasmsCarcinoma, Renal CellNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDebiopharm Group 3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active CompaniesDebiopharm Group 3B Pharmaceuticals GmbH Debiopharm International Sa

Inactive CompaniesN/A

Active IndicationsColorectal NeoplasmsCarcinoma, Renal CellNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A